GLP-1 Decreases Acetate Production by VAT of Non-Obese Individuals, While It Increases VAT Lactate and Alanine Production of Patients with Obesity and Pre-Diabetes. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.